Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ranbaxy
Ranbaxy
AstraZeneca Loses Bid to End ‘Pay-For-Delay’ Nexium Trial
Bloomberg
Mon, 11/24/14 - 12:47 pm
AstraZeneca
Ranbaxy
Nexium
generics
pay-for-delay
Ranbaxy Loses Bid to Block Rivals in Generic Drugs Fight
Bloomberg
Thu, 11/20/14 - 08:24 am
Ranbaxy
generics
Ranbaxy Sues the FDA for Rescinding Approval of two Generic Drugs
WSJ Pharmalot
Tue, 11/18/14 - 08:29 am
Ranbaxy
generics
FDA
Valcyte
Nexium
Ranbaxy Drops as FDA Withdraws Tentative Approval For Two Drugs
Bloomberg
Fri, 11/7/14 - 07:41 am
Ranbaxy
FDA
generics
Sun Pharma
Valcyte
Nexium
Oops! Did FDA Mistakenly Give Ranbaxy Approval to Sell Generic Nexium?
WSJ Pharmalot
Thu, 11/6/14 - 10:57 am
FDA
generics
AstraZeneca
Nexium
Ranbaxy
Ranbaxy loses six months exclusivity on Roche's antiviral drug
Yahoo/Reuters
Thu, 11/6/14 - 08:00 am
Ranbaxy
Roche
generics
Valcyte
Nexium
AstraZeneca
Pharma's top 10 M&A deals of 2014's first half
Fierce Pharma
Mon, 11/3/14 - 08:57 am
M&A
Actavis
Forest Labs
GSK
Novartis
Bayer
Merck
Mallinckrodt
Questcor Pharmaceuticals
Eli Lilly
Idenix
Nestle
Galderma
Sun Pharma
Ranbaxy
Aptalis
Abbott Labs
CFR
Ranbaxy books first profit in six quarters on exclusive drug launch
Reuters
Tue, 10/28/14 - 08:51 am
Ranbaxy
earnings
Ranbaxy Execs in the U.S. Depart Ahead of Sun Pharma Deal: Report
WSJ Pharmalot
Mon, 10/13/14 - 04:15 pm
Ranbaxy
Sun Pharma
M&A
Generic Sovaldi makers could pocket upwards of $600m says analyst
In-Pharma Technologist
Thu, 09/25/14 - 09:25 am
generics
Sovaldi
Gilead Sciences
hepatitis C
Mylan
Strides Arcolab
Cadila
Cipla
Hetero Labs
Ranbaxy
Sequent Scientific
Ranbaxy Faces Medicaid Pricing Probe by the Justice Department
WSJ Pharmalot
Thu, 09/18/14 - 09:01 am
Ranbaxy
Medicaid
DOJ
Gilead signs pact with 7 firms for cheap copies of hepatitis C drug
Yahoo/Reuters
Mon, 09/15/14 - 08:49 am
Gilead Sciences
Sovaldi
generics
hepatitis C
Cipla
Ranbaxy
Cadila
Mylan Labs
Strides Arcolab
Hetero Drugs
Sequent Scientific
Jumping into global M&A mix key to India growing its pharma industry
Fierce Pharma
Mon, 08/25/14 - 10:29 pm
India
M&A
Lupin
Ranbaxy
Sun Pharma
Ranbaxy Reports Quarterly Loss on Settlement Provision
Bloomberg
Tue, 07/29/14 - 03:35 pm
Ranbaxy
earnings
Ranbaxy gets FDA approval for Novartis's Diovan generic
Yahoo/Reuters
Fri, 06/27/14 - 09:25 am
FDA
Novartis
Ranbaxy
Diovan
generics
India
Ranbaxy decision shows why FDA reluctant to rely on European inspections
Fierce Pharma
Fri, 06/6/14 - 11:23 am
Ranbaxy
FDA
Europe
Sun Pharma Climbs After Court Removes Stay on Ranbaxy Buy
Bloomberg
Mon, 05/26/14 - 07:10 pm
Ranbaxy
India
Sun Pharma
Ranbaxy posts loss after write-offs on U.S. import bans
Reuters
Sat, 05/10/14 - 12:20 pm
Ranbaxy
earnings
Ranbaxy Reports Quarterly Loss Ahead of Sun Pharma Acquisition
Bloomberg
Fri, 05/9/14 - 10:37 am
Ranbaxy
earnings
Sun Pharma
M&A
Ranbaxy recalls nearly 30,000 packs of allergy-relief drug in U.S
Yahoo/Reuters
Fri, 05/2/14 - 08:29 am
Ranbaxy
recalls
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »